
Pivagabine
CAS No. 69542-93-4
Pivagabine( CXB-722 )
Catalog No. M26382 CAS No. 69542-93-4
Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 42 | Get Quote |
![]() ![]() |
5MG | 68 | Get Quote |
![]() ![]() |
10MG | 115 | Get Quote |
![]() ![]() |
25MG | 237 | Get Quote |
![]() ![]() |
50MG | 348 | Get Quote |
![]() ![]() |
100MG | 518 | Get Quote |
![]() ![]() |
500MG | 1098 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePivagabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
-
DescriptionPivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.(In Vivo):Pivagabine (CXB 722) (200 mg/kg; i.p.; twice a day for 4 days and 1 hour before killing on the 5th day) prevents the effects of foot-shock stress on CRF concentration in both brain regions.
-
In Vitro——
-
In VivoPivagabine (CXB 722) (200 mg/kg; i.p.; twice a day for 4 days and 1 hour before killing on the 5th day) prevents the effects of foot-shock stress on CRF concentration in both brain regions. Animal Model:Adult male Sprague-Dawley CD rats (200-250 g)Dosage:200 mg/kg Administration:i.p.; twice a day for 4 days and 1 hour before killing on the 5th day Result:Prevented the effects of foot-shock stress on CRF concentration in both brain regions. Reduced by 52% the CRF concentration in the hypothalamus but had no effect on that in the cerebral cortex.
-
SynonymsCXB-722
-
PathwayOthers
-
TargetOther Targets
-
RecptorGlutamate receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number69542-93-4
-
Formula Weight187.239
-
Molecular FormulaC9H17NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (267.04 mM)
-
SMILESCC(C)(C)C(=O)NCCCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andersson M, et, al. Inhibition of kainic acid binding to glutamate receptors by extracts of Gastrodia. Phytochemistry. 1995 Mar;38(4):835-6.
molnova catalog



related products
-
3-Sulfopropanoic aci...
3-Sulfopropanoic acid, a major metabolite of treprostinil and its prodrug ALZ-801, is an endogenous molecule present in the cerebrospinal fluid (CSF) of AD patients that inhibits the formation of Aβ42 oligomers.
-
Phlorizin dihydrate
Phlorizin dihydrate can significantly inhibit oxidative DNA damage.
-
PLH1215
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.